EHS
EHS

High Cost Trips Up Oral Chemotherapy Initiation

Denver—Many patients are abandoning or delaying initiation of their oral oncolytic therapies because of the high cost of the medication, according to the results of a survey of pharmacy staff and administrators presented at the 2018 annual meeting of the Hematology/Oncology Pharmacy Association (poster TR165).

Source link

EHS
Back to top button